Second, we observed that ZNF714 expression varies among different molecular subtypes in 10 tumor types, including BRCA, ESCA, glioblastoma (GBM), head and neck cancer (HNSC), low-grade glioblastoma (LGG), LIHC, LUSC, ovarian cancer (OV), pheochromocytoma and paraganglioma (PCPG), and UCEC (Figure 1B, Figure S1A). Here, ZNF714 is linked to ovarian carcinoma.